Skip to main content
Log in

Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter

  • Matters Arising
  • Published:

From Nature Metabolism

View current issue Submit your manuscript

The Original Article was published on 12 July 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Analysis of NMN using HPLC and LC–MS/MS.
Fig. 2: Hypercarb HPLC chromatograms of NMN in extracts from control and FK866-treated NIH3T3 cells and mouse primary hepatocytes.

References

  1. Schmidt, M. S. & Brenner, C. Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nat. Metab. https://doi.org/10.1038/s42255-019-0085-0 (2019).

  2. Grozio, A. et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat. Metab. 1, 47–57 (2019).

    Article  Google Scholar 

  3. Yoshino, J. & Imai, S. Accurate measurement of nicotinamide adenine dinucleotide (NAD+) with high-performance liquid chromatography. Methods Mol. Biol. 1077, 203–215 (2013).

    Article  CAS  Google Scholar 

  4. Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528–536 (2011).

    Article  CAS  Google Scholar 

  5. Trammell, S. A. & Brenner, C. Targeted, LCMS-based metabolomics for quantitative measurement of NAD+ metabolites. Comput. Struct. Biotechnol. J. 4, e201301012 (2013).

    Article  Google Scholar 

  6. Ramsey, K. M. et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651–654 (2009).

    Article  CAS  Google Scholar 

  7. Ratajczak, J. et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 7, 13103 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

S.I. and A.G. mainly wrote the correspondence. J.Y. conducted the experiments and analyses discussed in Fig. 1. A.G. performed the experiments and analyses discussed in Fig. 2. K.M., S.B., G.S., K.T., H.C.L., M.M. and Y.S. contributed to the preparation of the correspondence.

Corresponding author

Correspondence to Shin-ichiro Imai.

Ethics declarations

Competing interests

A.G. and S.I. are inventors on a patent (PCT/US18/46233) about the Slc12a8 NMN transporter, whose applicant is Washington University; it has been licensed by Teijin Limited. The other authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grozio, A., Mills, K., Yoshino, J. et al. Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nat Metab 1, 662–665 (2019). https://doi.org/10.1038/s42255-019-0086-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-019-0086-z

  • Springer Nature Limited

This article is cited by

Navigation